Adage Capital Partners Gp, L.L.C. Savara Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Savara Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,115,771 shares of SVRA stock, worth $5.69 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,115,771
Previous 6,753,701
68.67%
Holding current value
$5.69 Million
Previous $28.6 Million
77.32%
% of portfolio
0.01%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding SVRA
# of Institutions
141Shares Held
158MCall Options Held
55.6KPut Options Held
600-
Nea Management Company, LLC Timonium, MD24.5MShares$65.8 Million5.37% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$39.2 Million12.07% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$33.3 Million6.2% of portfolio
-
Vestal Point Capital, LP New York, NY10.8MShares$29 Million1.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.66MShares$23.3 Million1.59% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $307M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.